全文获取类型
收费全文 | 176825篇 |
免费 | 1147篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 1136篇 |
儿科学 | 6672篇 |
妇产科学 | 3017篇 |
基础医学 | 16734篇 |
口腔科学 | 1563篇 |
临床医学 | 12502篇 |
内科学 | 31208篇 |
皮肤病学 | 692篇 |
神经病学 | 16510篇 |
特种医学 | 8933篇 |
外国民族医学 | 1篇 |
外科学 | 28868篇 |
综合类 | 2395篇 |
一般理论 | 6篇 |
预防医学 | 18273篇 |
眼科学 | 2737篇 |
药学 | 9644篇 |
中国医学 | 624篇 |
肿瘤学 | 16464篇 |
出版年
2021年 | 45篇 |
2020年 | 31篇 |
2019年 | 52篇 |
2018年 | 21958篇 |
2017年 | 17391篇 |
2016年 | 19530篇 |
2015年 | 911篇 |
2014年 | 830篇 |
2013年 | 812篇 |
2012年 | 6983篇 |
2011年 | 21073篇 |
2010年 | 18810篇 |
2009年 | 11539篇 |
2008年 | 19543篇 |
2007年 | 21736篇 |
2006年 | 578篇 |
2005年 | 2192篇 |
2004年 | 3403篇 |
2003年 | 4360篇 |
2002年 | 2511篇 |
2001年 | 325篇 |
2000年 | 462篇 |
1999年 | 218篇 |
1998年 | 217篇 |
1997年 | 226篇 |
1996年 | 111篇 |
1995年 | 124篇 |
1994年 | 116篇 |
1993年 | 75篇 |
1992年 | 115篇 |
1991年 | 158篇 |
1990年 | 206篇 |
1989年 | 125篇 |
1988年 | 111篇 |
1987年 | 100篇 |
1986年 | 75篇 |
1985年 | 77篇 |
1984年 | 46篇 |
1983年 | 46篇 |
1982年 | 40篇 |
1980年 | 51篇 |
1978年 | 28篇 |
1974年 | 34篇 |
1970年 | 27篇 |
1969年 | 30篇 |
1938年 | 60篇 |
1937年 | 27篇 |
1934年 | 31篇 |
1932年 | 56篇 |
1930年 | 46篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
11.
12.
Contraceptive use is an important strategy for the prevention of unwanted pregnancy and avoidance of induced abortion. Of all the contraception methods, emergency contraceptive (EC) offers the last chance to achieve this. However, few studies have documented the use of EC among young people in Ghana. This study explored knowledge and usage of EC as well as the factors associated with it among University of Cape Coast students. Data were obtained on the knowledge and usage of ECs among University of Cape Coast students in 2013. Logistic regression analysis was used to investigate the association between students’ socio-demographic characteristics and EC knowledge and use. More male students (72 %) than females (59 %) were sexually active. Fifty-seven percent of the respondents had ever heard of EC and 36 % had ever used EC. Although males were more likely to be sexually active, females were more likely to have knowledge of EC use compared to males. The study underscores the need to increase awareness regarding EC among University students in order to offer them the opportunity that EC provides if other forms of contraceptives are missed. 相似文献
13.
14.
Gastroesophageal reflux is the most common benign disorder of the esophagus and laparoscopic Nissen fundoplication has become the standard surgical treatment for its treatment. In our area, where the use of bougie calibration is debatable, postoperative dysphagia is encountered often after this surgery although it is usually not permanent. The aim of this study was to investigate the effect of using a soft silicone tube 39 F in diameter for esophageal calibration during laparoscopic Nissen fundoplication on the incidence of postoperative dysphagia. We divided cases scheduled to undergo laparoscopic Nissen fundoplication between January 2009 and November 2010 into two groups, each consisting 25 patients. Esophageal calibration with a 39 F silicone orogastric tube was used for the first group while there was no operative calibration in the second group. The surgical duration was recorded; the presence and severity of the postoperative dysphagia was calculated by using a dysphagia severity scoring system during the 1-year postoperative follow-up. The dysphagia severity scores were significantly lower in group 1 than group 2 on the postoperative second day and at the end of the first week and first month. We did not find a significant difference at the end of the 6-month and first year. There was also no significant difference regarding surgery duration. The use of a soft orogastric tube 39 F in diameter for esophagus calibration during laparoscopic Nissen fundoplication has significantly decreased the incidence of postoperative transient dysphagia without affecting the duration of surgery. Although dysphagia gradually resolves in the majority of patients, a safe and easy calibration method for its prevention is worth developing, and we believe that the use of our method in larger series could be beneficial. 相似文献
15.
16.
J.J. Crowley R.B. Warren J.C. Cather 《Journal of the European Academy of Dermatology and Venereology》2019,33(9):1676-1684
Psoriasis is a chronic disease that requires long‐term treatment. Consequently, understanding the safety and tolerability of any potential treatment over time is critical to effective prescribing. The biologic agents currently available for the treatment of psoriasis target a number of different inflammatory cytokines involved in psoriasis disease pathogenesis. The monoclonal antibodies tildrakizumab, guselkumab and risankizumab target the p19 subunit that is specific to interleukin (IL)‐23. This article reviews published data on the safety of these IL‐23p19 inhibitors in patients with psoriasis compared with other currently available biologic therapies. Data from randomized, placebo‐ and active‐controlled phase 3 clinical trials show tildrakizumab, guselkumab and risankizumab to have a favourable risk–benefit profile in patients with moderate to severe psoriasis. No significant safety concerns have been observed for any of these IL‐23p19 inhibitors in the data published to date. The most commonly reported adverse events (AEs) associated with these agents in phase 3 studies were upper respiratory tract infections. No increase was seen in rates of serious infections, malignancies or major adverse cardiovascular events, with no signals suggestive of an elevated risk of opportunistic infections, active tuberculosis or reactivation of latent tuberculosis infection, mucocutaneous Candida infections, triggering or worsening of inflammatory bowel disease, demyelinating disorders or suicidal ideation. Selectively targeting IL‐23p19 may help avoid AEs that have been associated with biologic agents with other mechanisms of action. Data from long‐term extension studies and patient registries will further establish the safety profile of IL‐23p19 inhibitors for the treatment of moderate to severe psoriasis in routine practice. 相似文献
17.
18.
19.
20.